All Stories

  1. Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy

    Article • Patient Preference and Adherence, August 2018, Dove Medical Press

    KENJI KASHIWAGI, Dr Keiji Yoshikawa, Hirotaka suzumura

  2. Relationship between visual field progression and baseline refraction in primary open-angle glaucoma

    Article • Clinical Ophthalmology, August 2016, Dove Medical Press

    Dr Keiji Yoshikawa, Dr tairo kimura, Hirotaka suzumura

  3. Relationship between consecutive deterioration of mean deviation value and progression of visual field defect in open-angle glaucoma

    Article • Clinical Ophthalmology, November 2015, Dove Medical Press

    Dr Keiji Yoshikawa, Dr tairo kimura, Hirotaka suzumura

  4. The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]

    Article • Clinical Ophthalmology, July 2015, Dove Medical Press

    Dr Keiji Yoshikawa, Dr tairo kimura, Hirotaka suzumura

  5. Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma

    Article • Clinical Ophthalmology, July 2015, Dove Medical Press

    Dr Keiji Yoshikawa, Dr tairo kimura, Hirotaka suzumura

  6. The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]

    Article • Clinical Ophthalmology, March 2015, Taylor & Francis

    Dr Keiji Yoshikawa, Dr tairo kimura, Hirotaka suzumura

  7. The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients

    Article • Clinical Ophthalmology, September 2014, Taylor & Francis

    Dr Keiji Yoshikawa, Dr tairo kimura, Hirotaka suzumura

  8. Bimatoprost ophthalmic solution 0.03% lowered intraocularpressure of normal-tension glaucoma with minimal adverse events [Corrigendum]

    Article • Clinical Ophthalmology, July 2013, Taylor & Francis

    Dr tairo kimura, Hirotaka suzumura

  9. Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]

    Article • Clinical Ophthalmology, January 2013, Taylor & Francis

    Dr tairo kimura, Hirotaka suzumura

  10. Assessment of retinal sensitivity using a time-saving strategy in normal individuals

    Article • Clinical Ophthalmology, November 2012, Taylor & Francis

    Dr tairo kimura, Hirotaka suzumura

  11. Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events

    Article • Clinical Ophthalmology, September 2012, Taylor & Francis

    Dr tairo kimura, Hirotaka suzumura